DMJ-I-228 is a CD4-mimetic compound that targets HIV-1 by binding to the gp120 protein within the conserved Phe 43 cavity, which is adjacent to the CD4-binding site. This interaction effectively obstructs the binding of CD4, leading to the inhibition of HIV-1 infection. DMJ-I-228 is utilized in research focused on HIV-1 entry mechanisms and the development of antiviral therapies.
DMJ-I-228 is a CD4-mimetic compound that targets HIV-1 by binding to the gp120 protein within the conserved Phe 43 cavity, which is adjacent to the CD4-binding site. This interaction effectively obstructs the binding of CD4, leading to the inhibition of HIV-1 infection. DMJ-I-228 is utilized in research focused on HIV-1 entry mechanisms and the development of antiviral therapies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
